Literature DB >> 24423317

Expression of a mitochondrial progesterone receptor (PR-M) in leiomyomata and association with increased mitochondrial membrane potential.

Quanling Feng1, John R Crochet, Qunsheng Dai, Phyllis C Leppert, Thomas M Price.   

Abstract

CONTEXT: Clinical evidence supports a role for progestins in the growth of leiomyomata (fibroids). The mechanism(s) for this is thought to involve gene regulation via the nuclear progesterone receptors. Recently a mitochondrial progesterone receptor (PR-M) has been identified with evidence of a progesterone/progestin-dependent increase in cellular respiration. This observation raises a possible new mechanism whereby progesterone/progestin may affect the growth of fibroids.
OBJECTIVE: The goals of this research were to determine differential expression of PR-M in normal myometrium compared with the edge of a fibroid within the same uterus, to demonstrate a progestin-dependent increase in mitochondria membrane potential using an immortalized human myometrial cell line and to examine mitochondrial membrane potential in transfected cells expressing the complete coding sequence of PR-M.
DESIGN: Protein levels of PR-M, PR-B, PR-A, mitochondrial porin, and glyceraldehyde-3-phosphate dehydrogenase were determined in the myometrium and adjacent edge of a fibroid in 10 subjects undergoing hysterectomy for benign indications. Mitochondrial membrane potential was determined by fluorescent emission of 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolecarbocyanide iodine in hTERT-HM cells treated with R5020 and in transfected hTERT-HM cells determined by the fluorescent emission of tetramethylrhodamine methyl ester.
RESULTS: Higher levels of PR-M and mitochondrial porin were found in the fibroid edge compared with adjacent myometrium. Progestin increased mitochondrial membrane potential in hTERT-HM cells, which was not affected by a translation inhibitor. This effect was exaggerated in hTERT-HM cells expressing PR-M after transient transfection.
CONCLUSION: These studies suggest a mechanism whereby progesterone/progestin may affect the growth of fibroids by altering mitochondrial activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24423317      PMCID: PMC5393478          DOI: 10.1210/jc.2013-2008

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  44 in total

1.  Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes.

Authors:  A Mathur; Y Hong; B K Kemp; A A Barrientos; J D Erusalimsky
Journal:  Cardiovasc Res       Date:  2000-04       Impact factor: 10.787

2.  Assessing functional integrity of mitochondria in vitro and in vivo.

Authors:  M Degli Esposti
Journal:  Methods Cell Biol       Date:  2001       Impact factor: 1.441

3.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

4.  Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma.

Authors:  John M Norian; Carter M Owen; Juan Taboas; Casey Korecki; Rocky Tuan; Minnie Malik; William H Catherino; James H Segars
Journal:  Matrix Biol       Date:  2011-09-24       Impact factor: 11.583

5.  Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata.

Authors:  F Pedeutour; B J Quade; S Weremowicz; P Dal Cin; S Ali; C C Morton
Journal:  Genes Chromosomes Cancer       Date:  1998-12       Impact factor: 5.006

6.  Progesterone stimulates mitochondrial activity with subsequent inhibition of apoptosis in MCF-10A benign breast epithelial cells.

Authors:  Millie A Behera; Qunsheng Dai; Rachana Garde; Carrie Saner; Emily Jungheim; Thomas M Price
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

7.  Regression of uterine leiomyomata in response to the antiprogesterone RU 486.

Authors:  A A Murphy; L M Kettel; A J Morales; V J Roberts; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

Review 8.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

9.  Mechanical homeostasis is altered in uterine leiomyoma.

Authors:  Rebecca Rogers; John Norian; Minnie Malik; Gregory Christman; Mones Abu-Asab; Faye Chen; Casey Korecki; James Iatridis; William H Catherino; Rocky S Tuan; Namisha Dhillon; Phyllis Leppert; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

10.  A comparative ultrastuctural study of leiomyosarcoma, cellular leiomyoma, and leiomyoma of the uterus.

Authors:  A Ferenczy; R M Richart; T Okagaki
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

View more
  4 in total

Review 1.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

2.  A transcriptome-wide association study of uterine fibroids to identify potential genetic markers and toxic chemicals.

Authors:  Gayeon Kim; Gyuyeon Jang; Jaeseung Song; Daeun Kim; Sora Lee; Jong Wha J Joo; Wonhee Jang
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

3.  Transcriptome profile of the early stages of breast cancer tumoral spheroids.

Authors:  Rosario Pacheco-Marín; Jorge Melendez-Zajgla; Gonzalo Castillo-Rojas; Edna Mandujano-Tinoco; Alfredo Garcia-Venzor; Salvador Uribe-Carvajal; Alfredo Cabrera-Orefice; Carolina Gonzalez-Torres; Javier Gaytan-Cervantes; Irma B Mitre-Aguilar; Vilma Maldonado
Journal:  Sci Rep       Date:  2016-03-29       Impact factor: 4.379

Review 4.  Mechanisms Underlying the Regulation of Mitochondrial Respiratory Chain Complexes by Nuclear Steroid Receptors.

Authors:  Ami Kobayashi; Kotaro Azuma; Kazuhiro Ikeda; Satoshi Inoue
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.